Protection against filovirus infection: virus-like particle vaccines (Q37130463)

18 August 2017

1 reference

title

Protection against filovirus infection: virus-like particle vaccines (English)

1 reference

18 August 2017

Chinglai Yang

1

1 reference

18 August 2017

Ling Ye

series ordinal

2

1 reference

18 August 2017

Richard W Compans

series ordinal

3

1 reference

18 August 2017

publication date

1 April 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

333-344

1 reference

Hemorrhagic fever viruses as biological weapons: medical and public health management

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Exotic emerging viral diseases: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus: from discovery to vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Fruit bats as reservoirs of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Marburg virus infection detected in a common African bat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Defense against filoviruses used as biological weapons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

The ecology of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Molecular mechanisms of filovirus cellular trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Filovirus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola protein analyses for the determination of genetic organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola and Marburg viruses: pathogenesis and development of countermeasures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

An introduction to Ebola: the virus and the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Pathogenesis of filoviral haemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Pathogenesis of experimental Ebola virus infection in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

How Ebola and Marburg viruses battle the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Immunopathology of highly virulent pathogens: insights from Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus: unravelling pathogenesis to combat a deadly disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Status and challenges of filovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Epitopes involved in antibody-mediated protection from Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Protective efficacy of neutralizing antibodies against Ebola virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Role of natural killer cells in innate protection against lethal ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Structures of virus and virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Physical interaction of human papillomavirus virus-like particles with immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Vaccines for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Contribution of ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Analysis of Ebola virus and VLP release using an immunocapture assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus VP40-induced particle formation and association with the lipid bilayer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus-like particles protect from lethal Ebola virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola and Marburg virus-like particles activate human myeloid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

NKp30-dependent cytolysis of filovirus-infected human dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Human NK cells and their receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Vaccine research efforts for filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Effective post-exposure treatment of Ebola infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Successful topical respiratory tract immunization of primates against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.3.333

21 January 2018

Identifiers

DOI

10.1586/14760584.7.3.333

1 reference

18 August 2017

1 reference